Risk factor management: A practice guide

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 16, Issue SUPPL. 2, 2009, Pages

  Perk, Joep ^a  

^a Oskarshamn District Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; DIABETES MELLITUS; DYSLIPIDEMIA; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; HYPERTENSION; LIFESTYLE; MEDICAL PRACTICE; MEDICAL RESEARCH; METABOLIC SYNDROME X; NUTRITIONAL STATUS; OBESITY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; SHORT SURVEY; SMOKING CESSATION;

EID: 70349295989     PISSN: 17418267     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjr.0000359232.80893.77     Document Type: Short Survey

References (34)

1. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007; 28:2375-2414.
2. Petersen S, Peto V, Rayner M, Leal J, Luengo-fernández R, Gray A. European cardiovascular disease statistics: 2005 edition. London: British Heart Foundation; 2005.
3. Hemingway H, Marmot M. Evidence based cardiology: psychosocial factors in the etiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ 1999; 318:1460-1467.
4. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004; 109:1101-1107.
5. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, et al. Estimating the contribution of changes in classical risk factors to trends in coronary-event rates across the WHO-MONICA project populations. Lancet 2000; 355:675-687.
6. Reimer W, de Swart E, DeBacquer D, PyöräläK, Keil U. Smoking behaviour in European patients with established coronary heart disease. Eur Heart J 2006; 27:35-41.
7. Boersma E, Keil U, DeBacquer D, PyöräläK, Poldermans D, Leprotti C, et al. Blood pressure is insufficiently controlled in European patients with established coronary heart disease. J Hypert 2003; 21:1831-1840.
8. DeBacquer D, de Backer G, Cokkinos D, Keil U, Montaye M, Ostor E, et al. Overweight and obesity in patients with established cardiovascular disease: are we meeting the challenge? Eur Heart J 2004 25:121-128.
9. Prevention of coronary heart disease. Report of a WHO Expert Committee. WHO Technical Report Series 678. WHO Geneva. 1982.
10. Rouse A, Adab P. Is population coronary heart disease screening justified? A discussion of the National Service Framework for coronary heart disease (Standard 4). Br J Gen Pract 2001; 51:834-837. (Pubitemid 32958622)
11. US Dept of Health and Human Services. The health consequences of smoking: a report of the Surgeon general. www.surgeongeneralgov/library/ smokingconsequences. 2004
12. Bartecchi C, MacKenzie TD, Schrier RW. The human costs of tobacco use (1). N Engl J Med 1994; 330:907-912.
13. MacKenzie T, Bartecchi CE, Schrier RW. The human costs of tobacco use (2). N Engl J Med 1994; 330:975-980.
14. Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, et al. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA 1998; 279:119-124.
15. Lam T, He Y. Passive smoking and coronary heart disease: a brief review. Clin Exp Pharmacol Physiol 1997; 24:993-996.
16. Manson J, Tosteson H, Ridker PM, Satterfield S, Hebert P, O'Connor GT, et al. The primary prevention of myocardial infarction. N Engl J Med 1992; 326:1406-1416.
17. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Coch Database Syst Rev 2004; 3:CD000146.
18. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113:898-918.
19. Pirozzo S, Summerbell C, Cameron C, Glasziou P. Advice on low-fat diets for obesity. Cochrane database of systenatic reviews: reviews 2002 Issue 2. Chichester, UK: John Wiley & Sons, Ltd. doi: 10.1002/14651858.CD003640.
20. Franco O, De Laet C, Peeters A, Jonker J, Mackenbach J, Nusselder W. Effects of physical activity on life expectancy with cardiovascular disease. Arch intern Med 2005; 165:2355-2360.
21. Taylor R, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, et al. Exercisebased rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004; 116:682-692.
22. Aggarwal A, Ades PA. Exercise rehabilitation of older patients with cardiovascular disease. Cardiol Clin 2001; 19:525-536.
23. Vasan R, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kandel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345:1291-1297.
24. Neter J, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003; 42:878-884.
25. Pescatello L, Franklin B, Fagard RH, Farquhar W, Kelley GA, Ray C. American college of sports medicine position stand: exercise and hypertension. Med Sci Sports Exerc 2004; 36:533-553.
26. Pickering T, Shimbo D, Haas D. Ambulatory blood pressure monitoring. N Engl J Med 2006; 354:2368-2374.
27. Zarnke K, Feagan BG, Mahon JL, Feldman RD. A randomized study comparing a patient-directed hypertension management strategy with usual office-based care. Am J Hypertens 1997; 10:58-67.
28. Friedewald W, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
29. Abbott R, Wilson PW, Kannel WB, Castelli WP. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis 1988; 8:207-211. (Pubitemid 18135412)
30. Assmann G, Cullen P, Schulte H. The munster heart study (PROCAM). Results of follow-up at 8 years. Eur Heart J 1998; 19 (Suppl A):A2-A11.
31. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001; 358:2026-2033.
32. Meisinger C, Loewel H, Mraz W, Koenig W. Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study. Eur Heart J 2005; 26:271-278.
33. Conroy R, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24:987-1003.
34. Executive summary of the third report of the National cholesterol education program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ill). JAMA 2001; 285:2486-2497.